Navidea Biopharmaceuticals Inc
F:NO1A

Watchlist Manager
Navidea Biopharmaceuticals Inc Logo
Navidea Biopharmaceuticals Inc
F:NO1A
Watchlist
Price: 0.046 EUR
Market Cap: 4.6m EUR

Wall Street
Price Targets

NO1A Price Targets Summary
Navidea Biopharmaceuticals Inc

There are no price targets for NO1A.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Navidea Biopharmaceuticals Inc Competitors:
Price Targets
LGND
Ligand Pharmaceuticals Inc
27% Upside
1801
Innovent Biologics Inc
33% Upside
PRQR
ProQR Therapeutics NV
350% Upside
196170
Alteogen Inc
23% Upside
ABOS
Acumen Pharmaceuticals Inc
209% Upside
ORY
Oryzon Genomics SA
129% Upside
COYA
Coya Therapeutics Inc
200% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
31% Upside

Revenue
Forecast

Revenue Estimate
Navidea Biopharmaceuticals Inc

For the last 8 years the compound annual growth rate for Navidea Biopharmaceuticals Inc's revenue is -43%. The projected CAGR for the next 2 years is 261%.

-43%
Past Growth
261%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Navidea Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Navidea Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NO1A's stock price target?
Not Available

NO1A doesn't have any price targets made by Wall Street professionals.

What is Navidea Biopharmaceuticals Inc's Revenue forecast?
Projected CAGR
261%

For the last 8 years the compound annual growth rate for Navidea Biopharmaceuticals Inc's revenue is -43%. The projected CAGR for the next 2 years is 261%.

Back to Top